張 渭文

Medicine & Life Sciences

1. Chemoradiotherapy 100%
2. Cholangiocarcinoma 96%
3. Adjuvant Chemotherapy 75%
4. Adjuvant Chemoradiotherapy 71%
5. Adjuvant Radiotherapy 69%
6. Taiwan 66%
7. Breast Cancer Lymphedema 63%
8. Propensity Score 62%
9. Sentinel Lymph Node 51%
10. Induced Hyperthermia 50%
11. Lymphedema 49%
12. Hyperthyroidism 44%
13. Radiotherapy 44%
14. Macular Degeneration 43%
15. Hypothyroidism 42%
16. Drug Therapy 40%
17. Cohort Studies 35%
18. Survival 35%
19. Neoplasm Metastasis 35%
20. Weight Loss 34%
21. Adenocarcinoma 32%
22. Confidence Intervals 31%
23. Meta-Analysis 31%
24. Breast Neoplasms 30%
25. Systematic Reviews 30%
26. Breast 26%
27. Regression Analysis 24%
28. Arm 24%
29. Databases 23%
30. Adipose Tissue 23%
31. Population 22%
32. Sensitivity and Specificity 20%
33. Registries 20%
34. Survival Rate 15%
35. Therapeutics 14%
36. Jaundice 14%
37. Gold 14%
38. Paraffin 12%
39. Colonic Neoplasms 12%
40. Pathology 12%
41. Fluorescence 11%
42. Appendiceal Neoplasms 11%
43. Neoplasms 8%
44. Non-Randomized Controlled Trials 8%
45. Pain 8%
46. Logistic Models 7%
47. Odds Ratio 7%
48. Urbanization 7%
49. Eye 7%